Article
Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.
Clinical and vaccine immunology : CVI - 1 Oct 2009
Vordermeier H Martin, Dean Gillian S, Rosenkrands Ida, Agger Else M, Andersen Peter, Kaveh Daryan A, Hewinson R Glyn, Hogarth Philip J
Abstract excerpt
Tuberculosis (TB) remains one of the most important infectious diseases of humans and animals. Mycobacterium bovis BCG, the only currently available TB vaccine, demonstrates variable levels of efficacy; therefore, a replacement or supplement to BCG is required. Protein subunit vaccines have shown promise but require the use of adjuvants to enhance their immunogenicity. Using the protective mycobacterial antigen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
